Jonathan Rowlinson

538 total citations
16 papers, 319 citations indexed

About

Jonathan Rowlinson is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Jonathan Rowlinson has authored 16 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Genetics and 4 papers in Oncology. Recurrent topics in Jonathan Rowlinson's work include Glioma Diagnosis and Treatment (6 papers), Mesenchymal stem cell research (3 papers) and PARP inhibition in cancer therapy (3 papers). Jonathan Rowlinson is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Mesenchymal stem cell research (3 papers) and PARP inhibition in cancer therapy (3 papers). Jonathan Rowlinson collaborates with scholars based in United Kingdom, United States and Italy. Jonathan Rowlinson's co-authors include Martin Gering, Costanza Emanueli, Carlotta Reni, Marco Meloni, Rajesh Katare, Federica Riu, Helen Spencer, Elisa Avolio, Paolo Madeddu and Gianni D. Angelini and has published in prestigious journals such as Blood, Circulation Research and Scientific Reports.

In The Last Decade

Jonathan Rowlinson

15 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Rowlinson United Kingdom 9 179 105 98 87 47 16 319
Mariana Valente Portugal 10 198 1.1× 92 0.9× 157 1.6× 71 0.8× 34 0.7× 18 350
Annick Daniëls Belgium 10 203 1.1× 105 1.0× 163 1.7× 105 1.2× 21 0.4× 15 425
Paula Müller Germany 11 235 1.3× 140 1.3× 199 2.0× 96 1.1× 71 1.5× 20 457
Clara Gallina Italy 9 155 0.9× 101 1.0× 98 1.0× 93 1.1× 106 2.3× 12 349
Sherry Boozer Panama 7 269 1.5× 156 1.5× 168 1.7× 73 0.8× 34 0.7× 7 462
Shing-Jyh Chang Taiwan 6 230 1.3× 138 1.3× 101 1.0× 42 0.5× 44 0.9× 6 417
Maritza E. Mayorga United States 12 219 1.2× 60 0.6× 136 1.4× 41 0.5× 48 1.0× 14 432
Masakuni Tokunaga Japan 5 221 1.2× 80 0.8× 223 2.3× 113 1.3× 33 0.7× 6 379
Yasunobu Nishiwaki Japan 5 241 1.3× 81 0.8× 81 0.8× 36 0.4× 39 0.8× 6 389
Timothy Starosta United States 8 254 1.4× 118 1.1× 160 1.6× 47 0.5× 19 0.4× 9 466

Countries citing papers authored by Jonathan Rowlinson

Since Specialization
Citations

This map shows the geographic impact of Jonathan Rowlinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Rowlinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Rowlinson more than expected).

Fields of papers citing papers by Jonathan Rowlinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Rowlinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Rowlinson. The network helps show where Jonathan Rowlinson may publish in the future.

Co-authorship network of co-authors of Jonathan Rowlinson

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Rowlinson. A scholar is included among the top collaborators of Jonathan Rowlinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Rowlinson. Jonathan Rowlinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Serra, Riccardo, Stuart Smith, Jonathan Rowlinson, et al.. (2024). Neurosurgical application of olaparib from a thermo-responsive paste potentiates DNA damage to prolong survival in malignant glioma. British Journal of Cancer. 131(11). 1858–1868. 3 indexed citations
2.
Rowlinson, Jonathan, et al.. (2023). M6A RNA MODIfiCATION AND A DRIVER OF CELLULAR PLASTICITY AND INTRA-TUMOURAL HETEROGENEITY IN GLIOBLASTOMA. Neuro-Oncology. 25(Supplement_3). iii7–iii7.
4.
Rowlinson, Jonathan, Anbarasu Lourdusamy, Salah Abdelrazig, et al.. (2021). Intratumour heterogeneity in microRNAs expression regulates glioblastoma metabolism. Scientific Reports. 11(1). 15908–15908. 13 indexed citations
5.
Smith, Stuart, Jonathan Rowlinson, David Onion, et al.. (2020). Metabolism-based isolation of invasive glioblastoma cells with specific gene signatures and tumorigenic potential. Neuro-Oncology Advances. 2(1). vdaa087–vdaa087. 20 indexed citations
6.
Smith, Stuart, Betty Tyler, Gareth J. Veal, et al.. (2019). Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste. Clinical Cancer Research. 25(16). 5094–5106. 40 indexed citations
7.
Smith, Steven R., Riccardo Serra, Jonathan Rowlinson, et al.. (2019). P11.60 Neurosurgical delivery of the poly ADP ribose polymerase-1 inhibitor olaparib from a thermo-responsive biodegradable paste potentiates radiotherapy and prolongs survival. Neuro-Oncology. 21(Supplement_3). iii57–iii57. 1 indexed citations
8.
Rowlinson, Jonathan, Chris Denning, Jaime Hughes, et al.. (2019). Characterisation of the invasive tumour niche using astrocyte-glioblastoma organoids and decellularised human brain. Neuro-Oncology. 21(Supplement_4). iv7–iv7. 1 indexed citations
9.
Smith, Stuart, Riccardo Serra, Jonathan Rowlinson, et al.. (2019). Neurosurgical delivery of the poly ADP ribose polymerase-1 inhibitor olaparib from a thermo-responsive biodegradable paste potentiates radiotherapy and prolongs survival. Neuro-Oncology. 21(Supplement_4). iv2–iv2. 1 indexed citations
10.
Spencer, Helen, Eva Jover, William Cathery, et al.. (2019). Role of TPBG (Trophoblast Glycoprotein) Antigen in Human Pericyte Migratory and Angiogenic Activity. Arteriosclerosis Thrombosis and Vascular Biology. 39(6). 1113–1124. 15 indexed citations
12.
Ascione, Raimondo, Jonathan Rowlinson, Elisa Avolio, et al.. (2015). Migration towards SDF-1 selects angiogenin-expressing bone marrow monocytes endowed with cardiac reparative activity in patients with previous myocardial infarction. Stem Cell Research & Therapy. 6(1). 53–53. 12 indexed citations
13.
Avolio, Elisa, Marco Meloni, Helen Spencer, et al.. (2015). Combined Intramyocardial Delivery of Human Pericytes and Cardiac Stem Cells Additively Improves the Healing of Mouse Infarcted Hearts Through Stimulation of Vascular and Muscular Repair. Circulation Research. 116(10). e81–94. 104 indexed citations
14.
Spencer, Helen, Sadie C. Slater, Jonathan Rowlinson, et al.. (2015). A Journey From Basic Stem Cell Discovery To Clinical Application: The Case of Adventitial Progenitor Cells. Regenerative Medicine. 10(1). 39–47. 11 indexed citations
15.
Katare, Rajesh, Federica Riu, Jonathan Rowlinson, et al.. (2013). Perivascular Delivery of Encapsulated Mesenchymal Stem Cells Improves Postischemic Angiogenesis Via Paracrine Activation of VEGF-A. Arteriosclerosis Thrombosis and Vascular Biology. 33(8). 1872–1880. 53 indexed citations
16.
Rowlinson, Jonathan & Martin Gering. (2010). Hey2 acts upstream of Notch in hematopoietic stem cell specification in zebrafish embryos. Blood. 116(12). 2046–2056. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026